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Houston, Texas, USABackground and Aims: Previous studies show that microendoscopic images can be interpreted visually to
identify the presence of neoplasia in patients with Barrett’s esophagus (BE), but this approach is subjective
and requires clinical expertise. This study describes an approach for quantitative image analysis of microendo-
scopic images to identify neoplastic lesions in patients with BE.
Methods: Images were acquired from 230 sites from 58 patients by using a ﬁberoptic high-resolution microen-
doscope during standard endoscopic procedures. Images were analyzed by a fully automated image processing
algorithm, which automatically selected a region of interest and calculated quantitative image features. Image
features were used to develop an algorithm to identify the presence of neoplasia; results were compared with
a histopathology diagnosis.
Results: A sequential classiﬁcation algorithm that used image features related to glandular and cellular
morphology resulted in a sensitivity of 84% and a speciﬁcity of 85%. Applying the algorithm to an independent
validation set resulted in a sensitivity of 88% and a speciﬁcity of 85%.
Conclusions: This pilot study demonstrates that automated analysis of microendoscopic images can provide
an objective, quantitative framework to assist clinicians in evaluating esophageal lesions from patients with BE.
(Clinical trial registration number: NCT01384227 and NCT02018367.) (Gastrointest Endosc 2016;83:107-14.)Highly prevalent in the United States, Barrett’s esoph-
agus (BE) is a major risk factor for the development
of esophageal adenocarcinoma. The incidence rate of
esophageal adenocarcinoma is rapidly increasing in the
Western World, with an estimated 600% increase in inci-
dence over the last 40 years.1-4 Moreover, most cases ofns: BE, Barrett’s esophagus; HRME, high-resolution
cope.
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when treatment is challenging, resulting in signiﬁcant
morbidity and a poor 5-year survival rate.5 Early diagnosis
of neoplasia in patients with BE is challenging. Even with
routine endoscopic surveillance, it is difﬁcult to identify
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High-resolution microendoscopic images for diagnosis in Barrett’s esophagus Shin et aland ﬂat and not visible on standard endoscopy. Endos-
copy with random 4-quadrant biopsies is the accepted
surveillance of BE for identifying the presence of
dysplasia. However, 4-quadrant biopsies every 2 cm of
the BE mucosa sample only a small fraction of the entire
segment of BE, which can range from 1 to 20 cm in
length, often resulting in sampling error. Random biopsy
protocols have been shown to miss >50% of neoplasia.6,7
Improving early detection of BE-associated neoplasia is,
therefore, critical to improving survival and quality of life
for patients.
Coupled with standard endoscopy, high-resolution opti-
cal imaging technologies have the potential to improve
diagnostic accuracy for the detection of precancerous and
cancerous lesions in patients with BE by allowing real-
time imaging with resolution that approaches that of con-
ventional histopathology. Confocal endomicroscopy can
distinguish esophageal neoplasia from benign BE mucosa
with high accuracy by providing images of tissue architec-
ture and cellular morphology, with subcellular resolution
throughout the esophageal epithelium. In several studies,
confocal endomicroscopy combined with high-deﬁnition
white-light endoscopy was shown to signiﬁcantly improve
the ability to detect BE-associated neoplasia.8,9 In a study
conducted by Sharma et al,9 the sensitivity and speciﬁcity
were 68.3% and 87.8%, respectively, when confocal endo-
microscopy was used in combination with high-deﬁnition
white-light endoscopy, compared with 34.2% and 92.7%,
respectively, for high-deﬁnition white-light endoscopy
alone.9 Despite the potential for improving detection of
esophageal neoplasia, current confocal platforms are avail-
able mostly in tertiary-care referral centers because of
high cost ($150,000-$300,000). We recently developed a
low-cost (<$5000) ﬁber-optic high-resolution microendo-
scope (HRME), capable of imaging tissue with subcellular
resolution comparable to that of confocal microendo-
scopy.10 Muldoon et al11 showed the feasibility of the
HRME for imaging various esophageal tissue types,
including squamous, BE, and high-grade dysplastic tissue
obtained by EMR. Pierce et al12 demonstrated the ability
of the HRME to differentiate high-grade dysplasia from
normal squamous mucosa and BE without dysplasia
in vivo from a patient with BE.
Most studies of high-resolution endoscopic imaging rely
on subjective visual interpretation. Interobserver and intra-
observer variability in the assessment of images impairs
reliable diagnosis. Quantitative analysis offers an objective
manner to examine images; the use of computer-aided
algorithms may reduce subjectivity among reviewers and
enhance reproducibility, resulting in improving diagnostic
accuracy. Such algorithms can be coupled with advanced
optical imaging techniques with the potential to allow
real-time in vivo diagnosis with high accuracy. The aim of
this study was to develop quantitative HRME image analysis
criteria for delineation of esophageal neoplasia in patients
with BE.108 GASTROINTESTINAL ENDOSCOPY Volume 83, No. 1 : 2016METHODS
Patients
Patients with known BE or BE with dysplasia who were
scheduled for routine surveillance endoscopy within an
academic gastroenterology practice in New York City or
who were referred from outside hospitals were recruited
for this study. Study participants were aged 18 years
and signed a written informed consent and authorization.
Persons who had an allergy to proﬂavine, active GI
bleeding, or contraindication to endoscopy were excluded
from the study. The study was reviewed and approved by
the Institutional Review Boards at Mount Sinai Medical
Center and Rice University. The study was registered on
Clinicaltrials.gov (registration number NCT01384227 and
NCT02018367).
An endoscopist performed a standard upper endo-
scopic examination. Areas of BE mucosa suspicious for
neoplasia during endoscopy were interrogated further
with the HRME. Before HRME imaging, a topical solution
(1-2 mL) of 0.01% proﬂavine in sterile phosphate buffered
saline solution was applied to the esophageal surface by
using a standard endoscopic spray catheter. Proﬂavine,
which was used under an investigational new drug appli-
cation (IND 102 217) from the U.S. Food and Drug
Administration, is a ﬂuorescent contrast agent that stains
cell nuclei.13 After application of proﬂavine, the ﬁberoptic
probe of the HRME was inserted through the biopsy
channel of the endoscope, and the distal tip was placed
in gentle contact with the mucosal surface. Real-time im-
aging was performeddat each site, video sequences of
approximately 3-second duration were acquired and
then saved to a ﬁle. HRME images also were obtained
from at least 2 of 4 sites selected for random quadrant bi-
opsy. At each site imaged with the HRME, the ﬁber probe
was used to make a superﬁcial dimple to mark the imaged
area. A biopsy of each imaged site was then done and
specimens submitted for routine histologic diagnosis.
The endoscopist completed a standard of care evaluation
by completing the remaining biopsies of the routine 4-
quadrant biopsy procedure and submitting these for
routine histologic diagnosis. All specimens were pro-
cessed and sectioned in a standardized manner. Slides
later were reviewed by 2 expert GI pathologists (A.P.,
D.R.) blinded to both the endoscopists’ clinical impres-
sions as well as the HRME images. Cohen’s kappa statistic
was used to assess the agreement of the pathologists.
Diagnosis was performed by using standard histologic
criteria14; based on consensus histologic diagnosis as
the criterion standard, samples were divided into the
following categories: squamous mucosa, gastric cardia,
BE metaplasia, low-grade dysplasia, high-grade dysplasia,
or adenocarcinoma. Squamous mucosa, gastric cardia,
BE metaplasia, and low-grade dysplasia were considered
to be nonneoplastic, whereas the remaining categories
were considered neoplastic.www.giejournal.org
Figure 1. Image analysis procedure: A, A circular region of interest is selected. B, Fiber pattern is associated with the structure of a ﬁber bundle. C, Fiber
bundle is removed by using Gaussian ﬁltering. D, The contrast of an image is enhanced by using adaptive histogram equalization. E, Nuclei are
segmented. The size distribution of glandular features is determined by using granulometry. F, Quantitative image features are calculated. ROI, region
of interest.
Shin et al High-resolution microendoscopic images for diagnosis in Barrett’s esophagusImaging system
The HRME system has been described previously in
detail.15 A bandpass-ﬁltered blue-light emitting diode
(FF01-452/45; Semrock, Rochester, NY; M455L2, Thorlabs,
Newton, NJ) provides light that passes through a dichroic
mirror (485DCLP; Chroma Technology Corp, Bellows Falls,
Vt) onto a ﬁber bundle (FIGH-30-850N; Fujikura, Tokyo,
Japan) with a 1-mm outer diameter that is placed in
contact with the tissue surface to be imaged. The ﬁber
bundle is composed of 30,000 optical ﬁbers with 4-mm
center-to-center spacing and a 720-mm ﬁeld of view. Fluo-
rescence emission returns through the ﬁber bundle and
is imaged through the dichroic mirror and a 550-nm
bandpass ﬁlter (FF03-550/88; Semrock, Rochester, NY).
The emission then passes onto the optical sensor of a
charge-coupled device camera (GRAS-14S5M; Point Grey,
Richmond, Canada). The system has a lateral and axial res-
olution of 4.4 and 20 mm, respectively. A laptop computer
controls the system and obtains and displays video at a
rate of 15 frames per second.
Flowchart for visual classiﬁcation of HRME
images of the esophagus
HRME images were reviewed for quality control by 2
reviewers (R.R.K., M.L.). First, one reviewer (M.L.) identi-
ﬁed a single representative image frame from each video
sequence. Second, the images selected from each video
were then reviewed independently for quality control by
the 2 reviewers, who were blinded to clinical impression
and histologic diagnosis. Images were rejected if at least
50% of the ﬁeld of view was out of focus or showed
evidence of motion artifact. Last, images that met quality
control requirements were then reviewed for the selection
of a single image with the best image quality per site.
Two reviewers familiar with HRME images of BE from
prior studies12,16 were asked to classify each image acquired
in this study as neoplastic or nonneoplastic. They were
blinded to histopathology diagnoses. To assist in the classi-
ﬁcation, each image was printed on a 3”  5” card, and re-
viewers independently arranged cards according to
classiﬁcation. Reviewers were interviewed after the exercisewww.giejournal.orgto allow the investigators to understand the rules they
used in classiﬁcation. A ﬂowchart was then created to
represent the sequential classiﬁcation steps followed in
reaching a visual assessment. The ﬂowchart consisted of de-
cision nodes structured in the form of “yes” or “no” ques-
tions that led to a speciﬁc answer choice. Each question
was chosen to describe differences in cell type, cell
morphology, and glandular structures, subsequently lead-
ing to each diagnostic category, and then was used to
extract relevant image features for the following classiﬁca-
tion analysis.
We also evaluated whether this ﬂowchart could aid
endoscopists in making correct visual reads with HRME
images of the esophagus. The digital HRME images were
reviewed by 3 endoscopists with HRME experience. By us-
ing the ﬂowchart, reviewers analyzed the entire set of im-
ages and recorded an impression for each image as 1 of the
5 categories. Results of visual image interpretation that
used the ﬂowchart were calculated for each reviewer.
Automated image analysis
Figure 1 illustrates the quantitative image analysis proce-
dure used in this study. At each image, the whole circular
ﬁeld of view was selected for analysis. Low-pass Gaussian
ﬁltering was applied to remove the background pattern
associated with the structure of the ﬁber bundle used for
HRME imaging.17 Because the images acquired in this study
exhibited different morphologic structures associated with
squamous epithelium, intestinal metaplasia, and neoplasia,
a variety of image features were explored for possible use in
a classiﬁcation algorithm. First, image intensity was calcu-
lated as a feature that could be used to separate squamous
tissue from glandular tissue because the ﬂuorescence inten-
sity of glands might be higher than that of squamous cell
nuclei. Second, images were segmented to identify cell
nuclei. Morphologic image processing and thresholding
were used to segment nuclei in each HRME image. Morpho-
logic processing (opening and smoothing) was used to
compensate for the nonuniform background. Once a
threshold was chosen by the histogram-based automated
thresholding method, nuclear and cytoplasmic regionsVolume 83, No. 1 : 2016 GASTROINTESTINAL ENDOSCOPY 109
TABLE 1. Histopathology diagnosis of measured sites
Histopathology diagnosis Training set Validation set
Nonneoplastic
Squamous mucosa 10 13
Gastric cardia 14 25
Barrett’s metaplasia 25 85
Low-grade dysplasia 9 14
Neoplastic
High-grade dysplasia 9 2
Adenocarcinoma 10 14
Total 77 153
High-resolution microendoscopic images for diagnosis in Barrett’s esophagus Shin et alwere separated by this threshold. After nuclear segmenta-
tion, nuclear-to-cytoplasmic area ratio, mean nuclear size,
and mean nearest internuclear distance were calculated
for each image. Last, granulometry was used to characterize
epithelial thickness and lumen size of glands, in addition to
nuclear size. Granulometry is a morphologic method to
calculate the size distribution of objects in an image without
explicitly segmenting each object.18 HRME images exhibit
bright nuclei and epithelial layers along with dark glandular
lumens. The size distribution of nuclei and epithelial layers
was calculated from each HRME image. Similarly, the size
distribution of glandular lumens was calculated from the
complement of each HRME image. From granulometry,
the most common size, kurtosis, and skewness of the distri-
bution of the following features were computed for each
image: epithelial thickness and glandular lumen size.
Automated image classiﬁcation
Features extracted from the HRME images then were
used to develop and evaluate an automated sequential
classiﬁcation algorithm to classify whether each imaged
site contained neoplastic tissue (high-grade dysplasia or
cancer) or was nonneoplastic (normal squamous mucosa,
gastric cardia, BE metaplasia, or low-grade dysplasia).
Each step of the classiﬁcation algorithm was modeled after
the corresponding decision node of the ﬂowchart devel-
oped from visual assessment. Two-class linear discriminant
analysis was used to develop a classiﬁcation algorithm at
each node; extracted image features were added one at a
time until classiﬁcation performance no longer improved.
Sensitivity and speciﬁcity were calculated for the sequential
classiﬁcation algorithm by using histologic diagnosis as the
criterion standard. Data obtained at The Mount Sinai
Medical Center from February 2, 2009 to July 28, 2011
were assigned to a training set to develop and optimize
the algorithm. The data obtained at The Mount Sinai Med-
ical Center from September 27, 2012 to November 21,
2014 were assigned to an independent validation set to
assess algorithm performance. Image analysis and classiﬁ-
cation are fully automated and require a total of 52 seconds
for a single image.110 GASTROINTESTINAL ENDOSCOPY Volume 83, No. 1 : 2016RESULTS
Participant information: patients and sites
A total of 93 participants were enrolled in this study;
corresponding pathology was available from 317 biopsy
sites in 61 patients with images. Only sites with corre-
sponding pathology results were considered for analysis.
The agreement between the pathologists was found to
be substantial, with a kappa statistic of 0.75. Consensus
diagnosis was reached on subsequent review for the study.
Two reviewers (R.R.K., M.L.) selected representative HRME
images from 230 sites that passed quality control review;
87 sites had no images that passed quality control review.
The remaining data set for subsequent analysis consisted
of 230 images from 230 sites in 58 patients. Of these sites,
195 were diagnosed as nonneoplastic, and 35 were diag-
nosed as neoplastic. The data obtained from February 2,
2009 to July 28, 2011 were assigned to a training set that
consisted of 77 images from 77 sites in 31 patients. The re-
maining data obtained from September 27, 2012 to
November 21, 2014 were assigned to an independent vali-
dation set that consisted of 153 images from 153 sites in
27 patients. Table 1 shows the histologic diagnosis of the
measured sites available for further analysis.Visual interpretation with ﬂowchart
Figure 2 shows the sequential ﬂowchart that was devel-
oped for visual classiﬁcation. Images from the training
set were categorized into one of the following categories:
normal squamous mucosa, gastric cardia, BE metaplasia,
or neoplastic. Observers were ﬁrst asked whether glands
were visible in the HRME image. If not, images were clas-
siﬁed as neoplastic if nuclei were crowded and as normal
squamous tissue if nuclei were not crowded. If glands
were visible, the epithelial layer was thin, and the lumen
was large, the images were classiﬁed as gastric cardia. If
not, the observers were asked whether the glandular
epithelium showed loss of regular architecture. Images
with regular glandular architecture were classiﬁed as BE
metaplasia, whereas those with loss of regular architecture
were classiﬁed as neoplastic.
By using the sequential ﬂowchart, 3 endoscopists
performed visual image classiﬁcation, resulting in an
average sensitivity of 81% (95% conﬁdence interval [CI],
73%-88%) and an average speciﬁcity of 76% (95% CI,
50%-100%), with a kappa statistic of 0.39, indicating fair
agreement.Classiﬁcation performance
Quantitative image features were calculated. Relevant
image features were selected as described to develop a
sequential classiﬁcation algorithm with optimal perfor-
mance. Figures 3A and B illustrate the resulting classiﬁca-
tion tree of the training and validation sets and show
the performance of each node in the tree. At node 1 ofwww.giejournal.org
Figure 2. Flowchart for visual classiﬁcation. Scale bars represent 100 mm. LGD, low-grade dysplasia.
Shin et al High-resolution microendoscopic images for diagnosis in Barrett’s esophagusthe classiﬁcation tree, the most common epithelial thick-
ness and intensity of the epithelial layer were chosen to
classify whether or not each image contained glandular tis-
sue. At node 2, the nuclear-to-cytoplasmic ratio was chosen
to classify each image as neoplastic or nonneoplastic squa-
mous tissue. The most common lumen size and kurtosis of
lumen size were chosen at node 3 to classify each image as
cardia or not. The skewness of epithelial thickness was
chosen at node 4 to classify each image as neoplastic or
nonneoplastic glandular tissue. By using the sequential
classiﬁcation algorithm in the training set, 16 of 19 sites
were correctly classiﬁed as neoplastic, and 49 of 58 sites
were correctly classiﬁed as nonneoplastic, resulting in a
sensitivity of 84% and a speciﬁcity of 85%. Applying the al-
gorithm to the validation set resulted in a sensitivity of
88% and a speciﬁcity of 85%; 14 of 16 sites were correctly
classiﬁed as neoplastic, and 116 of 137 sites were correctly
classiﬁed as nonneoplastic.DISCUSSION
In this study, we demonstrated that HRME imaging
could discriminate BE with neoplasia from benign esopha-
geal tissue including normal squamous, BE without
dysplasia, and BE with low-grade dysplasia by using quanti-
tative image analysis and sequential classiﬁcation analysis.
A classiﬁcation algorithm was created by sequential analysis
of image features within the images, which representedwww.giejournal.orgdifferences in tissue architecture and cellular morphology
between nonneoplastic and neoplastic esophageal tissue.
The sequential classiﬁcation algorithm was able to distin-
guish between nonneoplastic and neoplastic tissue with
a sensitivity of 84% and a speciﬁcity of 85%. Preservation
and Incorporation of Valuable Endoscopic Innovations
thresholds suggested by the guidelines developed by The
American Society for Gastrointestinal Endoscopy are a
per-patient sensitivity of 90% or greater, speciﬁcity of
80% or greater, and negative predictive value of 98% or
greater.19 Because of the small number of patients en-
rolled in the present study, we performed per-biopsy anal-
ysis. Our classiﬁcation algorithm resulted in a sensitivity
of 88%, speciﬁcity of 85%, and negative predictive value
of 98% in an independent validation set. Given the results,
an estimated negative predictive value would be sufﬁ-
ciently high in a low prevalence setting, but results must
be conﬁrmed in a larger data set to support the use of
the HRME with quantitative image analysis as an appro-
priate approach for imaging of BE.
In several studies with confocal endomicroscopy,
confocal imaging criteria for BE neoplasia were established
and evaluated. Pohl et al20 evaluated the use of confocal
endomicroscopy in the detection of neoplasia in 296 sites
from 38 patients with BE and achieved a sensitivity of 80%
and a speciﬁcity of 94.1%, with a corresponding negative
predictive value of 98.9%. Similarly, in a study conducted
by Gaddam et al,21 confocal imaging criteria for dysplastic
BE were established and evaluated by using 50 confocalVolume 83, No. 1 : 2016 GASTROINTESTINAL ENDOSCOPY 111
Figure 3. Resulting classiﬁcation trees. A, The training set. B, The validation set. A bar graph on top indicates the total number of images in the data set.
Bar graphs on the bottom indicate the number of images classiﬁed as one of the categories. N/C, nuclear to cytoplasmic; LGD, low-grade dysplasia.
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Shin et al High-resolution microendoscopic images for diagnosis in Barrett’s esophagusimages, resulting in a sensitivity of 76% and a speciﬁcity
of 85%. Wallace et al22 established confocal imaging
criteria in a training set of 20 BE images and tested it in
an independent validation set of 20 BE images. The study
reported a sensitivity of 88% and a speciﬁcity of 96%.
Confocal endomicroscopy has shown high accuracy for
detection of neoplasia; however, interobserver and intra-
observer variability exist in the interpretation of images ob-
tained with this technique.23-25 Rigorous diagnostic criteria
by using quantitative image analysis can reduce this subjec-
tivity and provide consistent diagnosis with high accuracy.
Muldoon et al16 developed quantitative image analysis
criteria for HRME images from either endoscopically re-
sected or tissue biopsy samples to distinguish between
neoplastic and nonneoplastic esophageal mucosa. The
quantitative analysis that used textural features within the
images achieved a sensitivity of 87% and a speciﬁcity of
85%, whereas human analysis for the same images
achieved an average sensitivity and speciﬁcity of 87% and
53%, respectively.
The quantitative classiﬁcation algorithm described in
this article has the potential to improve the accuracy and
reproducibility for detection of esophageal neoplasia by
providing an objective means to classify images with
improved consistency. This approach may be of use to cli-
nicians, especially in low-resource settings. Also, it is noted
that this sequential classiﬁcation algorithm used intuitive
images features that corresponded well to ones used for
visual interpretation of the HRME images, such as epithe-
lial cell morphology and glandular architecture of BE.
Several other studies also have proposed quantitative
analysis of HRME images for diagnosis of neoplasia in pa-
tients with oral neoplasia,26,27 cervical neoplasia,28,29 and
esophageal squamous cell carcinoma.30 Analysis used in
these studies, however, used nuclear segmentation to
distinguish differences in cell morphology of neoplastic
tissue. It is difﬁcult to extend this approach to analysis of
images from patients with neoplasia in the glandular
epithelium, which exhibits differences not only in nuclear
morphology but also in glandular architecture.12,31 The
quantitative classiﬁcation algorithm presented here could
be applied to any analysis of HRME images of the gland-
ular epithelium in which a variety of tissue types exist.
Furthermore, confocal imaging of the GI epithelium could
be advantaged by this quantitative sequential classiﬁcation
analysis.
A limitation of this study is the small ﬁeld of view
(720 mm in diameter) of the HRME. Often, dysplastic
changes in BE occur focally; the HRME may not image
the small area of dysplasia identiﬁed in the larger biopsy
specimen. The solution to this limitation could be to use
a video mosaic method during imaging, which is an
emerging technique to increase the acquired ﬁeld of
view.32 Another limitation is that 30% of sites were excluded
because of bad image quality because they were out of
focus or had motion artifact. Technical improvements inwww.giejournal.orgthe frame rate of imaging devices may minimize motion
artifact during future image acquisition. Also, the current
algorithm requires a total of 52 seconds to process and
classify an image, which limits the ability to perform
automated analysis at the time of endoscopy. Further im-
provements in execution speed may enable an automated
frame-by-frame analysis.
The use of the HRME and the quantitative diagnostic
algorithm presented here could impact the application of
HRME as a useful tool in clinical practice by providing a
cost-effective and reliable method for assisting clinicians
in detecting esophageal neoplastic lesions during endos-
copy. Further evaluation of this classiﬁcation algorithm in
real time will be necessary in clinical practice.REFERENCES
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